Who Owns SELLAS Life Sciences Group Stock?
NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 33.16%
- Held by insiders
- 1.64%
- Institutional holders
- 267
- Institutions 33.2%
- Insiders 1.6%
- Public and other 65.2%
Who owns SELLAS Life Sciences Group stock?
Institutional investors own about 33.2% of SELLAS Life Sciences Group's shares, spread across 267 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.64% of SLS.
The largest institutional holders are Blackrock Inc. (8.01%), State Street Corporation (5.14%) and Vanguard Capital Management LLC (4.43%). Together, the top 10 institutions control 25.3% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their SLS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SLS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 16.18M | 8.01% | +7.4% |
| State Street Corporation | 10.37M | 5.14% | -20.2% |
| Vanguard Capital Management LLC | 8.94M | 4.43% | +8.7% |
| Geode Capital Management, LLC | 5.17M | 2.56% | +5.9% |
| Vanguard Portfolio Management LLC | 2.30M | 1.14% | +6.3% |
| Susquehanna International Group, LLP | 2.05M | 1.02% | +416.4% |
| Northern Trust Corporation | 1.62M | 0.80% | +27.0% |
| Morgan Stanley | 1.51M | 0.75% | +22.2% |
| UBS Group AG | 1.49M | 0.74% | +18.6% |
| Vanguard Fiduciary Trust Co | 1.44M | 0.71% | +8.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SLS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.91M | 2.93% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 5.67M | 2.81% |
| iShares Trust-iShares Russell 2000 ETF | 5.21M | 2.58% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.13M | 1.06% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.07M | 1.02% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.88M | 0.93% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 1.08M | 0.54% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 926.17K | 0.46% |
| iShares Trust-iShares Micro-Cap ETF | 634.38K | 0.31% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 546.80K | 0.27% |
Frequently asked questions
Who is the largest shareholder of SELLAS Life Sciences Group?
Blackrock Inc. is the largest institutional shareholder of SLS, owning 8.01% of shares outstanding (16.18M shares) as of its latest 13F filing.
What percentage of SELLAS Life Sciences Group is owned by institutions?
Institutions own about 33.2% of SLS shares and 33.7% of the public float.
How much of SELLAS Life Sciences Group do insiders own?
Insiders, such as officers and directors, own about 1.64% of SLS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.